Accendra Health gets NYSE notice after 30-day average share price falls below $1
ACH•Accendra Health received an NYSE notice on Oct. 6, 2026, after its average closing share price stayed below $1 for 30 trading days. It has six months to regain compliance and is reviewing a reverse stock split, subject to shareholder approval.
1. NYSE listing notice
Accendra Health received an NYSE notice on Oct. 6, 2026, for failing the $1.00 minimum share-price listing standard after its average closing price was below $1.00 for 30 trading days. The notice does not trigger immediate delisting, and the company must respond within 10 business days.
2. Compliance options
The six-month cure period runs from the notice date. To regain compliance, the stock must close at or above $1.00 at month-end and have a 30-trading-day average closing price of at least $1.00. Options under review include a reverse stock split, subject to shareholder approval at the annual meeting expected in May 2027.
